Marc Thibonnier
Company: AptamiR Therapeutics
Job title: Founder & President
Seminars:
One Drug Multiple Targets: Simultaneously Modulating Several Target Genes in Obesity, Diabetes & MAFLD 1:30 pm
Developing targeting microRNA oligonucleotide therapeutics for cardiometabolic disorders Mice, rats, monkeys, and in silico: demonstrating proof of efficacy in vitro in primary cultures of human cells and animal models Modulating multiple target genes with miRNA ONTs to treat multi-factorial diseasesRead more
day: Day 2 Stream 1 PM